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Abstract
The contribution of microglia in neurological disorders is emerging as a leading dis-
ease driver rather than a consequence of pathology. RNAseT2-deficient leu-
koencephalopathy is a severe childhood white matter disorder affecting patients in
their first year of life and mimicking a cytomegalovirus brain infection. The early
onset and resemblance of the symptoms to a viral infection suggest an inflammatory
and embryonic origin of the pathology. There are no treatments available for this dis-
ease as our understanding of the cellular drivers of the pathology are still unknown.
In this study, using a zebrafish mutant for the orthologous rnaset2 gene, we have
identified an inflammatory signature in early development and an antiviral immune
response in mature adult brains. Using the optical transparency and the ex utero
development of the zebrafish larvae we studied immune cell behavior during brain
development and identified abnormal microglia as an early marker of pathology. Live
imaging and electron microscopy identified that mutant microglia displayed an
engorged morphology and were filled with undigested apoptotic cells and undigested
substrate. Using microglia-specific depletion and rescue experiments, we identified
microglia as drivers of this embryonic phenotype and potential key cellular player in
the pathology of RNAseT2-deficient leukoencephalopathy. Our zebrafish model also
presented with reduced survival and locomotor defects, therefore recapitulating
many aspects of the human disease. Our study therefore placed our rnaset2 mutant
at the forefront of leukodystrophy preclinical models and highlighted tissue-specific
approaches as future therapeutic avenues.
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1 | INTRODUCTION
In the central nervous system (CNS), developmental apoptosis is criti-
cal for the formation of a healthy brain, eliminating excess neurons
produced during development (Dekkers, Nikoletopoulou, & Barde,
2013; Meier, Finch, & Evan, 2000; Nijhawan, Honarpour, & Wang,
2000). Dying neurons are cleared by the main phagocyte in the CNS—
the microglia—as part of a necessary immune response which allows
natural clearing of apoptotic neurons. However, disordered immunity
in the brain is also a feature of many neurological disorders and plays
a crucial role in the onset and progression of many neurodegenerative
and white matter diseases.
White matter disorders such as leukodystrophies are character-
ized by myelin defects and white matter degeneration. The early
onset of clinical symptoms includes loss of motor function and cogni-
tive decline, with patients often dying at a young age (Bielschowsky &
Henneberg, 1928). Patients as young as a few months old can present
with neurological deficits, suggesting a fetal origin of the disease. At
least 200 rare leukodystrophies have been identified to date, many of
which are caused by the dysfunction of oligodendrocytes and subse-
quent loss of myelin integrity (United Leukodystrophy Foundation,
2019). More recently, the contribution of microglia and neu-
roinflammation to disease pathology has been recognized, prompting
reclassification of these diseases and a requirement for further under-
standing of the mechanisms underlying disease progression (Kevelam
et al., 2016; van der Knaap & Bugiani, 2017).
Microglial activation and increased immune activity have
recently been detected even before the onset of myelin loss. Evi-
dence from postmortem studies suggested that microglial activa-
tion preceded the reduction of myelin viability in patients suffering
from metachromatic leukodystrophy and X-linked adrenoleukodys-
trophy (Bergner et al., 2019). Mouse models of Krabbe's disease,
another fatal leukodystrophy, showed similar microglial activation
before myelin loss, with elevated innate immune markers even
before microglial activation (Potter et al., 2013; Snook et al., 2014).
The phenotype of another common leukodystrophy, Aicardi
Goutières Syndrome (AGS), resembled a cytomegalovirus brain
infection with early upregulation of type I interferon being central
to the pathology (Crow & Manel, 2015). Understanding whether
the immune system is a driver of the disease rather a consequence
may uncover new avenues for therapeutic interventions to treat
these otherwise incurable diseases.
The development of animal models to study leukodystrophies
in vivo has been invaluable for testing therapies (Biffi et al., 2004;
Launay et al., 2017; Marshall et al., 2018; Priller et al., 2001); however,
many of those models fail to recapitulate the key aspects of the
human disease. We have previously generated a zebrafish model for
the Ribonuclease T2 (RNAseT2)-deficient leukoencephalopathy
through knockout of the zebrafish rnaset2 gene, orthologous to
its human equivalent (Haud et al., 2011). Similar to AGS,
RNAseT2-deficient leukoencephalopathy is another severe leukodys-
trophy with clinical manifestations resembling a congenital cytomega-
lovirus brain infection. This disorder affects children in their first year
of life and is characterized by white matter lesions, subcortical cysts
and calcification, with severe psychomotor and sensorineural hearing
impairments (Henneke et al., 2009). We and others have shown that
loss of RNAseT2 causes a lysosomal storage disorder (LSD) resulting
in the accumulation of ribosomal RNA (rRNA) in lysosomes due to
defects in ribosome autophagy (ribophagy) (Haud et al., 2011; Hillwig
et al., 2011). Adult rnaset2-deficient zebrafish develop white matter
lesions in adult brains, recapitulating this aspect of the human pathol-
ogy. Furthermore, rnaset2 deficiency triggers increased expression of
neuroinflammatory markers in the brain, further supporting a role for
immune activation in driving pathogenesis in leukodystrophies (Haud
et al., 2011). However, as for most rare monogenic leukodystrophies,
there is no treatment and the exact contribution of the immune sys-
tem to the pathology is still obscure.
We hypothesized that the early onset of RNAseT2-deficient leu-
koencephalopathy is caused by abnormal microglial activity during
neurodevelopment. In this current study, we utilize the ex utero
development of zebrafish larvae and its optical transparency to study
the impact of loss of rnaset2 early during brain development. Gene
expression analysis identified an upregulation of the immune system
in brains of larval and adult mutant. Using confocal imaging and high-
resolution electron microscopy (EM), we identified profoundly abnor-
mal microglia in rnaset2-deficient larvae, displaying an engorged mor-
phology and filled with undigested apoptotic cells. Using microglia
depletion, we showed that the increased number of apoptotic cells is
not due to increased neuronal cell death but to microglial failure at
digesting apoptotic bodies. Tissue-specific expression of rnaset2
targeting neurons and microglia rescued the embryonic pathological
phenotype in rnaset2 zebrafish mutants. Additionally, we found that
loss of rnaset2 was associated with reduced survival, and locomotor
defects at larval and adult stages.
Our findings identified dysfunctional microglia as early markers of
the pathology, highlighting a critical role for microglia in disease devel-
opment from its early stages. We propose a new mechanism by which
undigested storage material, previously identified only in neurons,
accumulates in microglia during neurodevelopmental apoptosis. This
bottleneck phenomenon identifies the microglia as the point of con-
gestion and final compartment for the undigested storage material
that might cause the identified neuroinflammation in the early brain,
with negative impact on brain integrity. Moreover, our results high-
light the benefit of neuron and microglia specific treatment
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approaches, opening the possibility of gene therapy and bone marrow
transplant to treat this rare leukodystrophy.
2 | METHODS
2.1 | Zebrafish husbandry and ethics
All zebrafish were raised in the Bateson Centre at the University of
Sheffield in UK Home Office approved aquaria and maintained follow-
ing standard protocols (Nüsslein-Volhard & Dham, 2002). Tanks were
maintained at 28C with a continuous recirculating water supply and
a daily light/dark cycle of 14/10 hr. All procedures were performed on
embryos less than 5.2 dpf which were therefore outside of the Ani-
mals (Scientific Procedures) Act, to standards set by the UK Home
Office. We used the Tg(mpeg1:mCherryCAAX)sh378 labeling the mem-
brane of macrophages and microglia (Bojarczuk et al., 2016), the previ-
ously ENU-generated rnaset2AO127 mutant and nacre wild type
(WT) to generate the new CRISPR/Cas9 rnaset2sh532 mutant.
2.2 | Microarray experiment and analysis
RNA was isolated from pooled dechorionated embryos at 28 hr
postfertilization (hpf), 3 day postfertilization (dpf) and dissected whole
adult brains using TRIzol (Invitrogen), following the manufacturer's
protocol. RNA integrity was confirmed using the Agilent 2100 Bio-
Analyzer, using only samples with an RNA integrity number of at
least 8.
Genome-wide expression profiling was performed using the
Zebrafish (v3) Gene Expression 4x44K Microarray (Agilent GPL14664)
containing 43,803 probes according to the manufacturer's instructions.
The probe sequences for this array platform were reannotated using the
ReAnnotator pipeline (Arloth, Bader, Röh, & Altmann, 2015) against ref-
erence genome danRer11 in order to obtain updated gene symbols.
Scanned raw data were normalized using quantile normalization,
and then filtered using the ReAnnotator results so that only probes
matching the exons of their target gene were retained. In the case of
genes with more than one probe, the probe with the highest inter-
quartile range was chosen as the representative probe for the gene.
Differential expression analysis was conducted using a linear
model framework and empirical Bayes' shrinkage implemented in the
limma Bioconductor package (Ritchie et al., 2015). Genes with an
adjusted p-value <.05 were taken forward to enrichment analysis with
the clusterProfiler Bioconductor package (Yu, Wang, Han, & He,
2012). Accession number for deposited dataset: GSE138493.
2.3 | Generation of rnaset2sh532 mutant
Synthetic SygRNA consisting of gene specific CRISPR RNAs (crRNA)
(Sigma) and transactivating RNAs (tracrRNA) (Merck) in combination
with cas9 nuclease protein (Merck) was used for gene editing.
TracrRNA and crRNA were resuspended to a concentration of 50 μM
in nuclease free water containing 10 mM Tris–HCl pH8. SygRNA
complexes were assembled on ice immediately before injection using
a 1:1:1 ratio of crRNA:tracrRNA:Cas9 protein. We used CHOPCHOP
to design the following crRNA sequences, where the PAM site is indi-
cated in brackets: rnaset2 (CCG)AGATCTGCTAGAACCATCTT. A 2 nl
drop of SygRNA:Cas9 protein complex was injected into one-cell
stage embryos. The resulting rnaset2 crispants were raised and
screened (see below) to select a suitable mutation for a stable line.
To determine the efficiency of CRISPR/Cas9 in inducing site-
specific mutations in injected larvae, we used high-resolution melt
curve (HMRC) analysis or PCR followed by Mwo1 restriction digest
(Sup. Figure 4C,D). Genomic DNA (gDNA) was extracted from individ-
ual larvae at 2dpf. Larvae were placed individually in 90 μl 50 mM
NaOH and boiled at 95 for 20 min. A total of 10 μl Tris–HCL pH8
was added to adjust the pH and mixed thoroughly. Gene specific
primers were designed using the Primer 3 web tool (http://primer3.ut.
ee/) and primers with the following sequences were used to amplify a
142 bp region: HRMCrnaset2_fw ACATACTACCAGAAATGGAG,
HMRCrnaset2_rev GTAGTGCCTAAATGCATTTG. HMRC analysis
was run using the CFX96 Bio-Rad quantitative PCR (qPCR) machine
with the Bio-Rad Precision Melt Analysis software using the following
reaction: gDNA 1 μl, 5μl DyNAmo Flash SYBR Green (Thermo Fisher),
0.5 μl of each primers 10 μM and 4 μl of water. The program used
was: Step 1:95C for 2 min, Step 2:95C for 10 s, Step 3:60C for
30 s, Step 4:72C for 30 s, Step 5:95C for 30 s, Step 6:60C for
10 min, Step 7:95C for 20 s with Steps 2–4 repeated 44 times and
increment of 0.2C every 10 s between Steps 6 and 7.
Potential founders were outcrossed and gDNA was extracted
from eight embryos from each progeny. HMRC was used to identify
INDELS in progenies, which were subsequently raised. Individual F1
adults were fin clipped and an 8 bp deletion causing a frame shift and
an early stop codon in a similar region as our previous rnaset2 mutant
was kept, given the “sh532” code and outcrossed to the Tg(mpeg1:
mCherryCAAX)sh378 line. Heterozygous animals were in-crossed and
progeny genotyped. Homozygous (rnaset2sh532) and wild type siblings
(WT) were selected, separated, and raised to adulthood. All experi-
ments were done on in-crosses from each tank, except when stated
otherwise in Sup. Figure S7.
2.4 | Quantitative PCR
RNA was extracted from brains of 3-month-old zebrafish suing the Tri-
zol/chloroform method. cDNA was synthetized using the SuperScript II
kit (Invitrogen) with 2 μg of RNA following manufacturer instructions
and diluted in 1:20 for qPCR. qPCR primers (Supplementary Table S1)
were tested for efficiency (85–105%) using a cDNA serial dilution. The
qPCR reaction was run in a CFX96 Bio-Rad machine as follow: 2 μl of
cDNA, 5 μl DyNAmo Flash SYBR Green (Thermo Fisher), 0.5 μl of each
primers 10 μM, and 3 μl of water. The program used was: Step 1:95C
for 2 min, Step 2:95C for 10 s, Step 3:60C for 30 s, Step 4:72C for
25 s, Step 5:95C for 30 s, Step 6:65C for 10 s, Step 7:95C for 20 s
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with Steps 2–4 repeated 39 times and increment of 0.2C every 10 s
between Steps 6 and 7. ΔCT was calculated using combined rpl13 and
ef1α as reference genes and expression relative to endogenous control
was calculated using the 2 (̂−ΔCT).
2.5 | Acridine orange assay
A pool of 20 5dpf WT and rnaset2sh532 mutant zebrafish larvae were
incubated for 20 min in 5 μg/ml of acridine orange (Life Technologies)
diluted in zebrafish E3 medium in the dark. After three 10 min washed in
clean E3, larvae were sedated and chopped finely with a scalpel then
transferred to a tube containing PBS with Liberase (Roche, reference
05401020001) at 40 μg/ml. Samples were incubated at 37C for 30 min,
with triturating of the mixture every 10 min to dissociate into a single cell
suspension. Samples were centrifuged at 1,000g for 6 min and
resuspended in Leibovitz 15 media containing 20% FBS and 5 mM
EDTA. After filtration to remove clumps of cells, samples were analyzed
using an ATTUNE Flow cytometry machine using the blue laser.
2.6 | Microglia morphology and count
To assess microglia morphology, 5dpf WT and rnaset2sh532 mutant
zebrafish larvae in the Tg(mpeg1:mCherryCAAX)sh378 background
were anesthetized and embedded in low melting point agarose con-
taining tricaine (0.168 mg/ml; Sigma-Aldrich) and imaged using a 40×
objective on a UltraVIEW VoX spinning disk confocal microscope
(PerkinElmer Life and Analytical Sciences) confocal spinning disk
microscope. A total of 100 μm stacks were acquired using 0.5 μm
slices. For image analysis, stacks of 50 μm were used to create a maxi-
mum projection and contours of each microglia (avoiding pigment
cells) were drawn using a pen tablet (Intuos from Wacom). Using Fiji,
we measured the circularity index (0–1) of each microglia and used
these values to assess the circularity of each cell with the value of
0 being not circular and 1 as being perfectly circular.
The same images were used to quantify the number of vacuoles
in each microglia. We used the labeled microglia membrane from Tg
(mpeg1:mCherryCAAX)sh378 to manually count vacuoles. A number of
vacuoles in microglia exceeding 20 were capped due to the difficulty
to be accurate after this number.
For microglia count, 5dpf larvae were imaged under the 10×
objective of the spinning disk microscope. Stacks of 100 μm were
generated with 2 μm thickness and microglia were counted in the
optic tectum region of each larvae by drawing a region of interest
around the optic tectum first using the reference bright-field image.
2.7 | Generation of irf8 morphants and crispants
The irf8 modified antisense oligonucleotide-morpholino (Gene Tools) was
used as previously reported by injecting 1 nl of 0.5 mM irf8 morpholino in
the yolk of one-cell stage embryos (Li, Jin, Xu, Shi, &Wen, 2011).
For crispant experiments, preparation and injection proceeded a
described above for the generation of rnaset2 mutant. The irf8 crRNA
sequence was kindly shared by Dr Daniel Lysko, Dr Will Talbot: irf8
GCGGTCGCAGACTGAAACAG(TGG) and 2 nl was injected at 50 ng/μl.
Successful irf8 crispant were phenotypically identified by injecting the
SygRNA:Cas9 complex into the Tg(mpeg1:mCherryCAAX)sh378 and
selecting embryos with no microglia at 5dpf. For control injection, we
replaced irf8 crRNA by scrambled crRNA: GACCTGAGGGA-
GCAAGATCC(TGG).
2.8 | TUNEL and 4C4 antibody dual staining
Fish larvae at 5dpf were fixed in 4% PFA and the TUNEL assay was per-
formed according to standard protocol using ApopTag Kit (Millipore).
Briefly, 5dpf larvae were incubated with proteinase K (20 μg/ml) for 2 hr
to permeabilize the tissue. Samples were fixed for 20 min in PFA at room
temperature before being placed at −20C in 1:2 acetone: ethanol for
7 min. Following incubation at 37C with 50 μl equilibration buffer for
1 hr, the reaction solution (16 μl TdT enzyme and 30 μl reaction buffer;
Apoptag Kit) was added to the embryos—again, incubating at 37C for
90 min. Embryos were then placed in 200 μl stop buffer (Apoptag kit) for
2 hr at 37C, before placing in antibody and blocking solution (62 μl anti-
Dig Fluorescein and 68 μl blocking solution) overnight at 4C. The fol-
lowing morning, samples were thoroughly washed in PBST (PST + 0.1%
Tween) and fixed in PFA for 30 min at room temperature. All liquid was
removed and embryos thoroughly rinsed with PBST between each stage
(5 min washes at room temperature, repeated three to four times as
needed). Samples at this stage can be imaged for TUNEL and costained
with antibodies by following a basic immunofluorescent staining proto-
col. In brief, samples were transferred to water and cracked with cold
acetone at −20C for 20 min. After water and then PBST rinses, samples
were blocked at RT in 10% sheep serum, 0.8% TritonX-100, 1%BSA in
PBST for 3 hr then incubated for 4 days in 1:50 4C4 antibody. After mul-
tiples PBST rinses, samples were incubated in secondary Cy5 anti-mouse
antibody at 1:500 for 2 days. Samples were then rinses in PBST and
mounted in low melting point agarose for imaging.
Samples were imaged on the inverted UltraVIEW VoX spinning
disk confocal microscope (PerkinElmer Life and Analytical Sciences)
using the bright-field and GFP channel by acquiring stacks of approxi-
mately 100 μm with 2 μm per slice. Using Fiji, the optic tectum region
was outlined with the free hand drawing tool using the bright-field
image and counting of number of apoptotic cells was performed using
the automatic thresholding and particle count. Manual colocalization
analysis was performed between TUNEL and 4C4. Analysis was
blinded until after counting was performed.
2.9 | Electron microscopy
Three WT and rnaset2sh532 mutant larvae at 5dpf were fixed in 2.5%
glutaraldehyde/0.1 M sodium cacodylate overnight and postfixed 2%
aqueous osmium tetroxide. Samples were dehydrated through a
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graded series of ethanol, and cleared in epoxypropane overnight on a
rotor and then infiltrated in 50/50 Araldite resin. This mixture was
replaced with two changes over 8 hr of fresh Araldite resin before
being embedded and cured in a 60C oven for 48–72 hr. Ultrathin
sections, approximately 85 nm thick, were cut on a Leica UC6 ultrami-
crotome onto 200 mesh copper grids. These were stained for 10 min
with saturated aqueous Uranyl Acetate followed by Reynold's lead cit-
rate for 5 min. Sections were examined using an FEI Tecnai Transmis-
sion Electron Microscope at an accelerating voltage of 80 kv. Electron
micrographs were recorded using Gatan Orius 1000 digital camera
and Gatan Digital Micrograph software.
2.10 | Apoptotic cells phagocytosis assays
Mutant and WT in the Tg(mpeg1:mCherryCAAX)sh378 background
were injected with equal ratio of phenol red solution, pDest (ubiq:
secAnnexinV-mVenus) construct (Morsch et al., 2015) at 80 ng/μl and
tol2 mRNA at 150 ng/μl at one-cell stage. The construct also con-
tained a red eye marker to identify positively injected fish. For time-
lapse analysis, positive 3dpf fish were sedated in 4.2% Tricaine and
one mutant and one WT were embedded together in low melting
point agarose into the capillary of the light sheet fluorescence micro-
scope. Time-lapse was performed on both samples at the same time,
acquiring images every 3 min for 2 hr. This was repeated twice. To
quantify the number of microglia containing a mVenus positive cells,
multiple fish were embedded into a dish containing a coverslip and
imaged on the inverted UltraVIEW VoX spinning disk confocal micro-
scope (PerkinElmer Life and Analytical Sciences), acquiring images
every 3 min for 2 hr. Uptake of apoptotic cells was quantified
throughout the video by all microglia and final number were used for
quantification. This experiment was repeated three times on different
batches of larvae.
2.11 | Cloning of rescue constructs and generation
of F1 lines
The rnaset2 cDNA was amplified from the PCGlobin vector previously




the BP reaction, the PCR product was cloned into the p221DONOR
vector which was used for the following LR reactions. To create the
positive control construct ubi:rnaset2:pA construct, we used the p50E-
ubi (Mosimann et al., 2011), pME-rnaset2, p30E-polyA into the
cryCFPpDest vector. To create the mpeg1:rnaset2:pA construct, we used
the p50E-mpeg1 (Ellett, Pase, Hayman, Andrianopoulos, & Lieschke,
2011), pME-rnaset2, p30E-polyA into the cryCFPpDest vector. To create
the huc:rnaset2:pA construct, we used the p50E-huc (cloned into p50E
using the following primers and restriction sites: Xhohuc_fwd
CGACTGCTCGAGCTTCCGGCTCGTATGTTGTG and Bamhuc_rev
GCAGGATCCGGTCCTTCGATTTGCAGGTC), pME-rnaset2, p30E-polyA
into the cryCFPpDest vector. Injections in rnaset2sh532 mutant consisted
of equal ratio of phenol red solution, vectors at 200 ng/μl and tol2
mRNA at 150 ng/μl at one-cell stage. Blue-eyed larvae were selected
at 5dpf before imaging and fixing for F0 analysis. For F1 analysis, F0
injected larvae were raised and founders were identified by screening
their progeny for blue-eyed larvae. These larvae were fixed at 5dpf for
TUNEL staining and immunofluorescence staining.
2.12 | Adult behavior tests
Daily observations of adult fish ensured early detection of tilted swim-
mers. These fish were closely monitored until they started spiraling at
which point they were humanly culled. Scoring of animals with spiral-
ing swimming phenotype was added up to have a monthly total. WT
adult fish did not develop tilted or spiraling swimming at any stage.
Survival was plotted onto a survival curve in GraphPad Prism and a
Log Rank Test with Mantel Cox posttest was used to determine statis-
tical difference between the two survival curves.
Behavioral analysis on nontilted swimmers was performed using
the Zebrabox tracking system and Zebralab software (ViewPoint Life
Science, France). Eight-month-old WT and mutant fish were matched
for sex and size, before being placed individually into open field tanks
and allowed to habituate for 30 min before recording. The walls of
each tank were covered with white paper to ensure the animals were
unable to interact or be distracted by their surroundings. Movement
was tracked over a period of 10 min under constant light conditions.
For quadrant analysis, the Zebrabox software was programmed such
that the open field tank was divided into four equal quadrants, where
Quadrant 1 was the most active quadrant while Quadrant 4 was the
least. Distance traveled by each fish was pooled and averaged—both
in total, and within each quadrant—in Microsoft Excel, with the
resulting data analyzed in GraphPad Prism.
2.13 | Larval behavior light/dark behavior test
As above, behavioral analysis was performed using the Zebrabox
tracking system and Zebralab software (ViewPoint Life Science).
To assess swimming behavior in response to light, 5dpf embryos
were transferred into 48-well plates (one embryo per well) and
allowed to habituate overnight. Swimming distance during a 1-min
interval was recorded for 20 min during an alternating dark–light pro-
tocol (5 min dark, followed by 5 min light). Total distance was calcu-
lated as the sum of the distance swam across all 20 intervals for a
single fish. Response to changes in light intensity was defined as the
distance swam in the minute after each light-to-dark or dark-to-light
transition. Distance traveled by each fish was pooled and averaged
and the resulting data were analyzed using GraphPad Prism. Outliers
that had not been tracked accurately over the recording period were
manually excluded based on abnormal angles and straight lines gener-
ated by the Zebralab software.
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2.14 | Statistical analysis
All statistical analysis were performed in GraphPad Prism where data
was entered using either a column (two samples, one variable only) or
a grouped table (more than two samples or two variables). Sample dis-
tribution was assessed using frequency of distribution analysis. Non-
parametric tests were used for not normally distributed dataset with
posttest (for multiple comparisons) described for each experiment. All
experiments were repeated three times using different batches of lar-
vae born on different dates, with the number of biological replicates
and n (experimental unit) number stated for each experiment in figure
legends. Contingency tables were used for adult zebrafish behavior
analysis with Fisher's exact test.
p-Values are indicated and a star system is used instead for graph
with multiple comparisons: * = p < .05, ** = p < .01, *** = p < .001,
**** = p < .0001. Following the recommendation of the American Sta-
tistical Association, we do not associate a specific p value with signifi-
cance (Wasserstein, Schirm, & Lazar, 2019).
3 | RESULTS
3.1 | Loss of rnaset2 triggers an inflammatory
response in the brain
Human patients suffering from the loss of functioning RNASET2 present
with clinical manifestations resembling a cytomegalovirus infection and
therefore suggesting an important role for the immune system in the
pathology of the disease. To investigate changes in the immune
response, we performed transcriptomics analysis at different timepoints
using the previously published zebrafish model for this disease, the
rnaset2AO127 mutant (Haud et al., 2011). Microarray analysis was per-
formed on whole rnaset2AO12 and WT siblings during early development
at 28 hr postfertilization (hpf) and 3 days postfertilization (dpf), and on
dissected brains of 1-year-old adult zebrafish (Figure 1a). Biological path-
way analysis identified 12 pathways differentially regulated in adult brain,
including seven involved in the immune system (Figure 1b). Genes from
“immune system,” “defense response,” and “innate immune response”
pathways were mostly upregulated in mutant samples (Figure 1b). Focus-
ing specifically on the innate immune response, 35% of the genes were
upregulated (Figure 1c) suggesting a strong immune response in the brain
of adult mutants. Biological pathway analysis did not reveal significant
changes in 28hpf samples, and only identified variations in cell cycle
pathways at 3dpf (Sup. Figure S1). Additionally, our primary analysis
showed that biological repeats from each time point clustered together
with the adult brain samples showing a clear separation from the embry-
onic time points (Sup. Figure S2).
Interestingly, most genes in the GO “response to virus” pathway
were upregulated in brains of adult rnaset2AO127 deficient zebrafish
(Sup. Figure S3), thus suggesting that the mutant zebrafish also pre-
sent with a “viral-infection-like” phenotype. This further demonstrated
that our rnaset2 mutant recapitulated the human disease resembling a
cytomegalovirus brain infection (Henneke et al., 2009).
3.2 | CRISPR/Cas9 rnaset2sh532 mutant
recapitulates previous rnaset2AO127 mutant
To further characterize the immune response triggered with the loss
of rnaset2, we generated a second mutant allele by CRISPR/Cas9 in
the rnaset2 gene by targeting the same exon as our previous
rnaset2AO127 mutant, as our previous mutant line was lost. This new
rnaset2sh532 mutant allele possesses an 8 bp deletion in Exon 5 (Sup.
Figure S4a), creating a premature STOP codon before the second cat-
alytic domain and resulting in a truncated rnaset2 protein (Sup.
Figure S4b), similar to our previous mutant (Haud et al., 2011). Homo-
zygous and WT sibling pairs were raised from a heterozygous in-cross
and genotyped by HRMC analysis and/or restriction digest (Sup.
Figure S4c,d). These fish were used to generate F2 homozygous
(rnaset2sh532) and WT siblings which were viable and fertile, as
observed with our previous mutant. The previous rnaset2AO127 mutant
had a characteristic high uptake of acridine orange, a dye accumulat-
ing in lysosomes highlighting the lysosomal storage defects (Haud
et al., 2011), a phenotype which is recapitulated by our rnaset2sh532
mutant (Sup. Figure S5).
To determine whether immune response genes were also
upregulated in the CRISPR mutant, we performed qPCR analysis on
brains from 3-month-old rnaset2sh532 mutant and WT siblings using
upregulated genes identified in the microarray profiling of
rnaset2AO127. Expression analysis of immune response genes con-
firmed upregulation of il1beta and antiviral genes (interferon ifnϕ1,
mxa, and isg15) (Figure 1d). Additionally, rnaset2 expression was
decreased threefold compared to WT siblings (Sup. Figure S6)
suggesting nonsense-mediated RNA decay. These results demonstrate
that our new CRISPR/Cas9 rnaset2sh532 mutant faithfully recapitulates
the previous ENU-generated mutant and can be used to further inves-
tigate the role of the immune system in the development of the
disease.
To test whether the immune response is also upregulated in
embryonic brain, we dissected heads of 5dpf larvae and used the
same panel of genes used on 3-month-old brains (Figure 1e). The
il1beta gene was found upregulated in 5dpf mutant brain suggesting
the presence of an inflammatory response in embryonic brain. Inter-
estingly, we found that this inflammatory response was not accompa-
nied by an increased antiviral response as detected in older brain
using the antiviral genes interferon ifnϕ1, mxa, and isg15. This points
toward a potential mechanism involving an initial inflammatory stimu-
lus during brain development, later followed by an antiviral response.
3.3 | Embryonic brains of rnaset2sh532 mutants
contained profoundly abnormal microglia
To further characterize this inflammatory signal in the larval brain, we
took advantage of the transparency of the zebrafish larvae to study
the behavior of brain immune cells in vivo. Macrophages enter the
brain at 2dpf and subsequently differentiate into microglia which are
both labeled by the membrane reporter line Tg(mpeg1:mCherryCAAX)
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sh378 (Ellett et al., 2011; Herbomel, Thisse, & Thisse, 2001). Confocal
imaging of the optic tectum at 5dpf revealed profound defects in
mutant microglia. Mutant microglia displayed an obvious abnormal
phenotype, with a higher circularity index (Figure 2a–c, p < .0001) and
containing a higher number of vacuoles labeled using the membrane
transgenic line Tg(mpeg1:mCherryCAAX)sh378 (Figure 2d, p < .0001).
Interestingly, this engorged phenotype was reduced in homozygous
mutants generated from a heterozygous in-cross, suggesting that
maternal contribution of rnaset2 in early development is critical for
maintaining a normal microglia morphology (Sup. Figure S7).
Increased immune response combined with abnormal microglia
can potentially trigger a stress signal to recruit more immune cells in
the brain. We counted the number of macrophages using the trans-
genic line Tg(mpeg1:mCherryCAAX)sh378 and found a higher number
of mCherry positive cells in mutant (Figure 2e,f, p = .0077). This result
suggested that circulating macrophages infiltrated the brain.
3.4 | Increased numbers of apoptotic cells in 5dpf
rnaset2
sh532 mutants are due to defects in apoptotic
cell degradation by microglia
Multiple signals can trigger macrophage brain entry, including neu-
rodevelopmental apoptosis which was described as the first event to
attract circulating macrophages into the developing brain (Casano,
Albert, & Peri, 2016; Xu, Wang, Wu, Jin, & Wen, 2016). In zebrafish,
this wave of neuronal apoptosis occurs between 1 and 2dpf and is
accompanied by an influx of embryonic macrophages which differenti-
ate into microglia and begin to phagocyte apoptotic cells—a clearance
that is completed by 5dpf (Casano et al., 2016; Herbomel et al., 2001;
Xu et al., 2016). To measure apoptosis in mutant brains, we labeled
apoptotic cells with fluorescein using the TUNEL ApopTag kit. Quanti-
fication of apoptotic cell number in the optic tectum identified a more
than twofold increase in mutant brains at 5dpf (Figure 3a,d,
p < .0001). Interestingly, we found no difference at the earlier time-
point of 3dpf (Sup. Figure S8), suggesting that the initial number of
dying neurons was unchanged in mutants.
We then hypothesized that the increased number of apopto-
tic cells observed at 5dpf was due the abnormalities identified in
microglia. To test this hypothesis, we undertook a microglia-
depletion approach by targeting the transcription factor irf8,
commonly used the block the production of embryonic macro-
phages (Li et al., 2011; Shiau, Kaufman, Meireles, & Talbot,
2015). Using a CRISPR/Cas9 approach with a single irf8 crRNA
resulted in a more robust depletion of microglia at 5dpf com-
pared to the commonly used irf8 antisense morpholino (Sup.
Figure S9). As expected and previously shown (Villani et al.,
2019), depletion of microglia in WT brains resulted in a threefold
increase numbers of apoptotic cells compared to scrambled
crRNA injected larvae at 5dpf (Figure 3b,–d, p < .0001). We
found that depletion of microglia in rnaset2sh532 mutants
resulted in the same number of apoptotic cells versus control
(Figure 3b–d, p = .34), suggesting that mutant microglia fail at
clearing the brain from apoptotic cells even when present. Inter-
estingly, depletion of microglia in mutant resulted in the same
number of apoptotic cells than in depleted WT (Figure 3b–d). We
therefore concluded that the rate of neuronal death during neu-
rodevelopmental apoptosis is normal in mutant larvae. Further-
more, our results suggest that the increased number of apoptotic
cells in rnaset2sh532 mutants is due to a defect in apoptotic cell
clearance by abnormal mutant microglia.
Clearing of apoptotic cells in the brain is performed by microglial
phagocytosis, a process starting by the engulfment of dead cells and
followed by degradation of the internalized cargo through fusion with
lysosomes. We noticed that most apoptotic cells in mutant brains are
in fact contained within microglia (Figure 3e,f), suggesting a defect in
digesting, rather than ingesting, apoptotic cells. To confirm that
mutant microglia can efficiently uptake dying neurons, we investi-
gated the engulfment activity of mutant microglia during the clearing
of neurodevelopmental apoptosis at 3dpf using live imaging. We
injected the destination vector ubiq:secAnnexinV-mVenus with Tol2
mRNA into the fluorescent reporter line Tg(mpeg1:mCherryCAAX)
sh378 to label apoptotic cells engulfment by microglia. Time-lapse
videos showed that mutant microglia were able to migrate toward
dying cells, form a phagocytic cup and phagocytose dying cells at 3dpf
(Sup. Figure S10c, Video S1). The number of engulfed apoptotic cells
was quantified on still images and showed no difference between
mutant and WT microglia (Sup. Figure S10b).
To understand how microglia could fail at digesting apoptotic
cells, we used EM to obtain high-resolution images of microglial intra-
cellular structure. Images of neurons from 5dpf mutant samples con-
firmed that most of the neurons contained large electron dense
F IGURE 1 Loss of rnaset2 triggers an inflammatory response in the brain. (a) Venn diagram of differentially expressed genes across the three
timepoints of rnaset2AO127 mutant and wild type (WT) samples used for microarray experiment. (b) Differential expression (DE) graph showing the
enriched pathways identified by clusterProfiler in adult brain. The proportion of individual genes belonging to each pathway is displayed in dark blue
for upregulated and light blue for downregulated expression. The p-value for the enrichment of each pathway is stated below the pathway name.
(C) Heatmap of genes belonging to innate immune response GO pathway showing normalized expression values and all replicates of the adult
timepoint. Genes are ordered according to the magnitude of difference between rnaset2AO127 mutant and WT samples (with red indicating higher
expression in mutant). Each row is annotated with the gene name and color-coded bars at the top to indicate whether the gene is upregulated (dark
blue) or downregulated (light blue) regulated, or not significant at the adjusted p-value threshold of .05. The −10log of the adjusted p-value is also
shown. (d,e) Quantitative PCR (qPCR) analysis of inflammatory il1beta and antiviral response genes: mxa, isg15, ifnΦ1 from dissected brain of
3-month-old (d) and dissected heads of 5dpf (e) WT siblings and rnaset2sh532. Expression relative to two reference genes combined rpl13 and ef1α.
n = 8 (d) and n = 6 (e), two-tailed Mann–Whitney U test, p value shown on individual graphs [Color figure can be viewed at wileyonlinelibrary.com]
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inclusions within their cell bodies as already identified in the previous
ENU rnaset2AO127 mutant (Figure 3g) (Haud et al., 2011). EM images
of mutant microglia showed enormous electron dense inclusions and
intact apoptotic cells contained within the microglia cell body
(Figure 3h). We therefore concluded that the higher count of apopto-
tic cells in the brains of rnaset2sh532 mutants is not due to impaired
microglial engulfment but a defect in digesting their content. This is
reminiscent of a defect in the lysosomal degradation pathway and
reinforces our initial published proposal that loss of rnaset2 causes an
LSD (Haud et al., 2011).
3.5 | Microglial-specific rescue of rnaset2 restores
embryonic phenotype in rnaset2sh532 mutant
Our findings suggest a new model whereby lysosomal defects
prevented microglia to digest apoptotic neurons during neu-
rodevelopmental apoptosis. As such, this LSD mechanism suggests
that replacing functioning rnaset2 protein within microglia will pre-
sent a therapeutic strategy to rescue the embryonic phenotype.
There are two possible approaches to restore functional rnaset2 in
microglia: directly by targeting microglia, or indirectly through neu-
ronal rescue. Neuronal rescue would resemble a gene therapy-like
approach, allowing the missing lysosomal rnaset2 protein to reach
surrounding microglia through exocytosis (cross correction) or
phagocytosis of dying neurons. We designed a genetic tissue-
specific rescue approach to restore rnaset2 expression in different
cell types, using the ubi promoter for ubiquitous expression serving
as positive control, the mpeg promoter to specifically target the
macrophage and microglia linage (Ellett et al., 2011), and the huc
promoter to target neurons. Rescue plasmids were built using gate-
way cloning and all constructs contained a WT rnaset2 middle entry
vector, and a blue eye marker to allow screening of positive larvae.
To avoid mosaicism and ensure a stable expression of the rnaset2
gene, F0 injected blue-eyed larvae were raised and screened for
founders. F1 blue-eyed larvae from separate founders were fixed at
5dpf and subsequently analyzed for microglial and apoptotic cell
number analysis. As expected, the positive control ubi:rnaset2 vec-
tor rescued the brain phenotype observed in the rnaset2sh532
mutants, such that there was no difference in microglia circularity
index compared to WT microglia (Figure 4a–d, p < .0001), and no
different in number of apoptotic cells (Figure 4a–c,e). Reexpression
of rnaset2 specifically in macrophages and microglia also rescued
microglial morphology and numbers of apoptotic cells (Figure 4a–e,
p < .001) and interestingly the same was observed with the neuro-
nal rescue (Figure 4a–e, p < .0001). Microglia cell count was par-
tially rescued by all constructs, although this did not reach
statistical significance (Figure 4f, p = .0152). These results demon-
strated that targeting microglia either directly or indirectly can
restore microglial morphological defects and their ability to digest
apoptotic neurons. This highlights cell-specific strategies for
targeted therapy, representing exciting therapeutic avenues for
treatment of rnaset2sh532 deficient leukoencephalopathy.
F IGURE 2 Microglia display impaired morphology and
increased number in rnaset2sh532 mutant (a) Diagram of a dorsal
view of 5dpf zebrafish larvae with red boxes highlighting the brain
region imaged in the panel (b) and (e). (b–d) Analysis of microglia
circularity in the optic tectum in 5dpf wild type (WT) siblings and
rnaset2sh532 larvae. (b) Representative images of microglia
morphology using the 40× objective. Scale bar 21 μm.
(c) Quantification of microglia circularity using the circularity index
analysis from Fiji. n = 48–50 larvae from three independent
experiments, two-tailed Mann–Whitney U test p = .6944.
(d) Quantification of numbers of vacuole in individual microglia.
Mutant counts were capped at 20 due to the lack of accuracy to
identify vacuole when there were too many in each cell.
n = 80–104 larvae from three independent experiments, two-tailed
Mann–Whitney U test p < .0001. (e,f ) Microglia/macrophage count
in the optic tectum (OT) of 5dpf WT siblings and rnaset2sh532
larvae. Representative images of the whole head with OT outlined
(dotted white line) (e) and quantification of mCherry positive cells
from the Tg(mpeg1:mCherryCAAX)sh378 reporter line labeling both
microglia and macrophages (f ). n = 19–22 larvae from three
independent experiments, two-tailed Mann–Whitney U test
p = .0077 [Color figure can be viewed at wileyonlinelibrary.com]
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3.6 | rnaset2sh532 mutants exhibit decreased
survival and abnormal behavior in adult and larval
stages
As the first generation of homozygous andWT siblings generated from gen-
otyped F2 reached adulthood, we noticed a clear tilted swimming pheno-
type in 8-month-old rnaset2sh532 mutants (Sup. Video S2). Tilted swimming
behavior deteriorated into abnormal spiraling (Sup. Video S3), at which point
they were not able to feed properly and were humanely culled. For this rea-
son, most of rnaset2sh532 mutants had to be culled before reaching
12 month old while WT siblings did not develop a tilted or spiraling swim-
ming behavior at any stage (Figure 5a). To perform an unbiased swimming
behavior analysis on the rest of the clutch, we used the ViewPoint system
and recorded normal swimming behavior for 10 min. WT adults exhibited
exploratory behaviors, demonstrated by visiting all four quadrants of the
tank equally (Figure 5b,c). Swimming and exploratory behaviors were signifi-
cantly altered in rnaset2sh532 adults, which swam in repetitive stereotyped
patterns restricted to a single quadrant in which they spent the majority of
their time (Figure 5b,c). Interestingly, swimming speed and distance traveled
was not different (Sup. Figure S11).
RNAseT2-deficient patients present with severe locomotor disabil-
ities, including spasticity and dystonia, which arise in the first year of the
patient life (Henneke et al., 2009). To assess locomotion in early life, we
performed locomotion tests at 5dpf using the Zebrabox ViewPoint sys-
tem. We measured the swimming activity of 5dpf rnaset2sh532 mutants
relative to age-matched WT siblings over 20 min, alternating light and
dark phases (Pant, Boespflug-Tanguy, & Pujol, 2019). We found that
rnaset2sh532 larvae were less active compared to WT siblings (Figure 5d–
g). Total swimming distance over a period of 20 min of alternating light
and dark was decreased in mutants compared to WTs, with hypoactivity
accentuated in dark phases (Figure 5f,g, p = .0223, p = .0482). These
early onsets of locomotor abnormalities and increased immune response
in the rnaset2sh532 larvae suggest that the brain integrity might be com-
promised during early stages of development.
4 | DISCUSSION
Using the transparency and the ex utero development of the zebrafish
embryos, we were able to identify profound microglia abnormalities
during neurodevelopment for the first time in a model of human
leukodystrophy. This study identified dysfunctional microglia as a new
early marker of the pathology in RNAseT2-deficient leu-
koencephalopathy. Our results also demonstrate that microglia-
specific interventions can rescue microglial defects in rnaset2-
deficient zebrafish, therefore highlighting a cell specific therapeutic
approach to be investigated in patients.
RNAseT2-deficient leukoencephalopathy was already pro-
posed to be classified as an LSD from our previous study, showing
accumulation of rRNA in neurons (Haud et al., 2011). In our new
CRISPR/Cas9 model, we showed that mutant microglia can detect
and uptake apoptotic cells normally during neurodevelopmental
apoptosis but failed to break down their ingested cargo. This
resulted in a higher number of apoptotic cells detected in mutant,
mainly contained within mutant microglia. Electron microscopy
confirmed our previously described dark inclusions in mutant neu-
rons (Haud et al., 2011) and identified much larger inclusions in
microglia alongside intact apoptotic cells. This is indeed reminiscent
of an LSD and reinforces our initial proposal. The specific
“engorged” morphology and the accumulation of undigested sub-
strate identified the microglia as the bottleneck of the system.
Undigested substrates can affect the cell in multiple ways, including
impaired degradation of pathogens by macrophages, disrupted
lysosome positioning in the cell or autophagy build-up (Marques &
Saftig, 2019). Here, we showed that accumulation of apoptotic cells
in saturated microglia could be the start of the pathology. Although
these microglial defects have not yet been described in
RNAseT2-deficient leukoencephalopathy patients, they still repre-
sent an early marker of the pathology and a potential therapeutic
target for RNASET2-deficient leukoencephalopathy.
To our knowledge, this is the first time that neurodevelopmental
apoptosis has been linked to defective microglial function in a LSD.
Nearly 50% of neurons die during neurodevelopmental apoptosis
(Dekkers et al., 2013; Nijhawan et al., 2000)—a key step of brain
development that relies on microglia to clear away dead cells. Like
many other LSDs and leukodystrophies, RNASET2-deficient leu-
koencephalopathy affects patients during the early years of life,
suggesting a fetal initial insult (Henneke et al., 2009; Rutherford &
Hamilton, 2019). Developmental apoptosis represents the first scav-
enging challenge for microglia, and although considered a normal
physiological event, we showed here that this extreme number of
apoptotic cells to clear could have a profound impact on microglia.
F IGURE 3 Increased number of apoptotic cells in 5dpf rnaset2sh532 mutant is due to dysfunctional microglia. (a–d) Higher number of apoptotic
cells in mutant is due to defective microglia and not excessive neuronal cell death. Representative images of apoptotic cells (as visualized by TUNEL
staining) in brains of 5dpf rnaset2sh532 mutants and wild type (WT) siblings in scrambled crRNA injected control (a) and following injection of irf8
crRNA (c). Scale bar 70 μm. (b) Diagram of experimental flow. Injection of irf8 crRNA or scrambled crRNA control was performed into one-cell stage
embryos, which were raised until 5dpf and microglia-depleted larvae were selected in irf8 crRNA injected animals. Control and depleted larvae were
fixed and stained for apoptotic cells using TUNEL assay and microglia using 4C4 antibody. (d) Quantification of apoptotic cells in the optic tectum
(OT). n = 15–28 from three independent experiments, using multiple two-tailed U test with Bonferroni's multiple comparisons test (****p < .0001).
(e–h) Undigested apoptotic cells are contained within microglia. (e) High resolution images of apoptotic cells (fluorescein TUNEL staining) and
microglia (4C4 magenta) in brains of 5dpf rnaset2sh532 mutants and WT siblings with apoptotic cells mainly appearing within microglia (white
arrowheads). Scale bar 20 μm. (f) Quantification of total number of apoptotic cells and number of apoptotic cells contained within microglia.
n = 26–28 from three independent experiments, using multiple two-tailed U test with Bonferroni's multiple comparisons test (****p < .0001). (g,h)
High-resolution electron microscopy images of 5dpf rnaset2sh532 mutants and WT siblings neurons (g) and microglia (h-magenta) with dark inclusion
bodies (blue arrowheads) and intact apoptotic cells (green) [Color figure can be viewed at wileyonlinelibrary.com]
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F IGURE 4 Tissue-specific rescue of rnaset2 restores embryonic phenotype in rnaset2sh532 mutant. (a) Diagram of a dorsal view of a 5dpf
zebrafish head with red box highlighting the region imaged in the next panels. (b) Representative confocal images of apoptotic staining (TUNEL)
combined with immunofluorescence for 4C4 labeling microglia in brains of 5dpf wild type (WT) siblings and rnaset2sh532 larvae. Scale bar 3 μm.
(c) Representative confocal images of apoptotic staining (TUNEL) combined with immunofluorescence for 4C4 labeling microglia in stable F1 5dpf
rnaset2sh532 larvae from founders injected at one-cell stage to rescue expression of the rnaset2 gene either ubiquitously (ubi), or in macrophages/
microglia (mpeg), or in neurons (huc). Scale bar 3 μm. (d) Quantification of microglia circularity measuring the circularity index. n = 78–141
microglia from three independent experiments, Kruskal–Wallis test with Dunn's multiple comparisons p < .0001. (e) Quantification of number of
apoptotic cells by TUNEL staining. n = 53–72 larvae from three independent experiments, Kruskal–Wallis test with Dunn's multiple comparisons
p < .0001. (f) Macrophage/microglia mCherry count after anti-RFP immunofluorescence staining. n = 16–21 larvae from three independent
experiments, Kruskal–Wallis test with Dunn's multiple comparisons p = .0152 [Color figure can be viewed at wileyonlinelibrary.com]
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Increased apoptosis in the brain acts as a signal for brain entry of
macrophages (Casano et al., 2016; Xu et al., 2016), which can explain
the increased number of microglia/macrophages observed in mutant
brains. Engorged microglia could potentially secrete stress factor,
become neurotoxic and trigger cumulative arrival of macrophages.
Our study identifies an early inflammatory signature in 5dpf larval
brain, but future microglia-specific transcriptomic studies will be infor-
mative to elucidate their inflammatory profile.
Tissue-specific rescue of rnaset2 expression using a neuronal or a
macrophage/microglia promoter restored microglia morphology and
the number of apoptotic cells present in mutant brains. Neuronal res-
toration of normal rnaset2 expression could contribute to microglial
rescue. Deficient microglia could inherit the corrected version of the
protein by “cross-correction,” a common phenomenon for lysosomal
enzymes that are secreted into the extracellular space and captured
by surrounding cells often observed after gene therapy or bone mar-
row transplant in LSD patients (Fratantoni, Hall, & Neufeld, 1968;
Penati, Fumagalli, Calbi, Bernardo, & Aiuti, 2017; Rastall & Amalfitano,
2015; Walkley et al., 1994).
Most importantly, to our knowledge, our zebrafish model is the first
de novo animal model of a leukodystrophy to recapitulate the patient
neuropathology throughout development and into adulthood. Murine
models of leukodystrophies have failed to reproduce all aspects of the
human disease, with a recent RNASET2-deficient rat model showing
deficiencies in object recognition memory but no locomotor or spatial
memory defects (Sinkevicius et al., 2018). rnaset2 zebrafish mutants
show hypoactivity in larval stages and tilted swimming in adulthood with
an impaired exploratory phenotype. The adult tilted swimming pheno-
type can be caused by defects in the vestibular righting reflex or motor
deficit (Kalueff et al., 2013). Such vestibular defects may be due to
impaired ear development or impairment of sensory neurons within the
inner ear (Whitfield, 2002) and may therefore recapitulate the sensori-
neural hearing loss diagnosed in patients (Henneke et al., 2009). Hence,
our study places the rnaset2sh532 zebrafish mutant at the forefront of
F IGURE 5 rnaset2sh532 mutants exhibit decreased survival and abnormal behavior in adult and larval stages. (a) Survival curve of rnaset2sh532
and wild type (WT) sibling. Death outcome is represented by humanely culling animals displaying a spiraling swimming phenotype. Log rank
Mantel–Cox test, p < .0001. n = 22. (b) Representative traces of movement from 8-month-old adults WT siblings and rnaset2sh532 in all four
quadrants, where quadrant number 1 representing the quadrant most visited and Quadrant 4 the least visited. Scale bar representing the size of
the tank used for the test. (c) Quantification of quadrant analysis in adult. n = 4 using a contingency table and a Chi-square analysis p < .0001.
(d,e) Examples of movement from 5dpf WT siblings (d) and rnaset2sh532 larvae during 1 min (e). (f,g) Swimming activity of 5dpf embryos as
measured by distance traveled across a 20 min period of alternating light and dark (f) and in dark phases only (g). n = 56–67 larvae from three
independent experiments, two-tailed Mann–Whitney U test p = .0223 (f) and p = .0482 (g) [Color figure can be viewed at wileyonlinelibrary.com]
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leukodystrophy preclinical animal models and will be used to develop
therapies targeting the microglial population.
Our study identifies an important role for the ribonuclease T2
protein in early brain development and reveals that deficient microglia
could underpin the pathology of RNAseT2-deficient leu-
koencephalopathy. We provide evidence to focus on therapies that
can target the microglial population, such as gene therapy and hema-
topoietic stem cell transplantation. These therapies are already being
used in clinical trials for LSDs and other types of leukodystrophies
(Penati et al., 2017; Rutherford & Hamilton, 2019; Schiller, Henneke, &
Gärtner, 2019) and could therefore be adapted to treat children suf-
fering from RNAseT2-deficient leukoencephalopathy.
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